TOP Web Exclusives

Navigating through the oncology landscape has become increasingly challenging. As a result, it is imperative for oncology practices today to stay abreast of the changes occurring in the field to succeed.

At the 2018 NCCN conference, Sharon H. Giordano, MD, MPH, FASCO, Professor of Medicine, Department of Breast Medical Oncology, M.D. Anderson Cancer Center, Houston, provided an update on the treatment of patients with HER2-positive breast cancer, noting an “explosion of new therapies” in recent years that have had a tremendous impact on survival.

Three cancer centers share their experiences related to the struggle of understanding wide variations in the application of sterile compounding and safe handling of oncology hazardous drugs, and the costs and operating burdens of compliance with and adherence to current pharmacy standards.

The National Prescription Drug Take-Back addresses a vital public safety and public health issue. Many patients are not aware that the medicines in their cabinets are highly susceptible to diversion, misuse, and abuse.
Adherence to certain strategies can aid pharmacists in successful navigation of our increasingly collaborative healthcare landscape.
At the National Comprehensive Cancer Network 20th Annual Conference, Mario E. Lacouture, MD, presented some clinical pearls that can guide the management of dermatologic toxicities.

Results 1 - 6 of 6